For the current REF see the REF 2021 website REF 2021 logo

Output details

1 - Clinical Medicine

University College London

Return to search Previous output Next output
Output 0 of 0 in the submission
Article title

A Phase I study of quisinostat (JNJ-26481585), an oral hydroxamate histone deacetylase inhibitor, in patients with advanced solid tumors.

Type
D - Journal article
Title of journal
Clinical Cancer Research
Article number
-
Volume number
19
Issue number
15
First page of article
4262
ISSN of journal
1078-0432
Year of publication
2013
URL
-
Number of additional authors
16
Additional information

The author made a substantial contribution to the conception and design of the study; to the organisation of the conduct of the study; to carrying out the study (including acquisition of study data); and to analysis and interpretation of study data.

The author helped draft the output; and critiqued the output for important intellectual content.

Interdisciplinary
-
Cross-referral requested
-
Research group
None
Citation count
0
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-